We further dissected the transcriptional wiring of tsNeus, based on which we showed a proof of concept that a strategy involving the targeting of Hippo-YAP pathway may selectively activate neutrophils to kill tumor cells derived from patients with refractory GC. Here, YAP1 is linked to neoplasm.